Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer

NCT03977233 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Ductal Adenocarcinoma (PDAC)
Cancer of Pancreas
Pancreatic Cancer, Adult
Pancreas Adenocarcinoma
Pancreatic Neoplasms
Pancreatic Cancer Non-resectable
Pancreatic Cancer Resectable

Interventions

DRUG: Oxaliplatin
DRUG: Leucovorin
DRUG: Irinotecan Hydrochloride
DRUG: 5-FU

Sponsor

UNC Lineberger Comprehensive Cancer Center